Beijing Haiaosi Biotechnology Co., Ltd. was established on June 13, 2025, with a registered capital of RMB 30 million, and operates primarily within the broad health industry. Currently, the company focuses on the in-depth development and efficient utilization of the *Acer truncatum* (purpleblow maple)—a strategic national resource.
Contact Us
